This concept covers the pharmacologic principle of matching antihypertensive drug classes to patient comorbidities in cardiovascular pharmacology, based on each class's mechanism of action and its interaction with coexisting pathophysiology. Drug classes covered include thiazide diuretics, beta blockers, ACE inhibitors, ARBs, calcium channel blockers, and aldosterone receptor blockers, each with characteristic indications and contraindications derived from their underlying physiologic effects (e.g., renal calcium handling, cardiac conduction, angiotensin-mediated arteriolar tone, and potassium regulation). The organizing theoretical principle is that antihypertensive selection is comorbidity-driven rather than uniform, since each mechanism of blood-pressure lowering interacts differently with a patient's underlying disease state.
This concept covers the pharmacologic principle of matching antihypertensive drug classes to patient comorbidities in cardiovascular pharmacology, based on each class's mechanism of action and its in…